KIR3DL3 INHIBITORS AND IMMUNE CELL ACTIVATING AGENTS

Abstract: the present disclosure pertains to kir3dl3 inhibitors (e.g., anti-kir3dl3 antibodies or antigen-binding fragments thereof) and immune cell activating agents and uses thereof, such as to modify immune effector cells.

Inventor(s): Scott Chappel, Bijan Etemad-Gilbertson, Detlev Biniszkiewicz

CPC Classification: C07K16/2803 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250171533